JUMP Prevalence of Sarcopenia and Chemobrain in Post-cancer Patients
JUMP Prevalence of Sarcopenia and Chemobrain in Post-cancer Patients
Recruiting · NCT05800535 · Registry updated 2025-11-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| JUMP Prevalence of Sarcopenia and Chemobrain in Post-cancer Patients | Atrophy, Chemically-Induced Disorders, Chemotherapy-Related Cognitive Impairment, Cognition Disorders, Cognitive Dysfunction, Drug-Related Side Effects and Adverse Reactions, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, cancer, cognitive disorder, muscular atrophy, neoplasm, nervous system disorder, psychiatric disorder | Recruiting | Not stated | 2025-11-21 | NCT05800535 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hospices Civils de Lyon | 429 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Service de Rhumatologie, Hospices Civils de Lyon, Groupement Hospitalier Lyon Sud | Pierre-Bénite | France | 2 |